The world is rushing with vaccines, while vaccines may have little effect against the South African mutant



[ad_1]

Nordea’s newsletter on coronavirus draws attention to a study published on January 19, the essence of which is that there are doubts about the effectiveness of the vaccines developed so far due to the variant of the South African virus, because this variant can elude the human immune response . that vaccines seek to induce.

It has been heard for weeks that the British variant is capable of increasing infection compared to the original coronavirus strain (said to be 50-70% more infectious), although recent results suggest it may cause more deaths, but The South African variant has also been increasingly dangerous for a long time.

Nordea’s material is definitely interesting in this regard too, because in the meantime it has started and developed.

it also calls into question the effectiveness and efficiency of global vaccine competition.

At home, according to Sunday’s results, enough vaccine supplies were received to vaccinate a total of 165,000 people, of whom 145,257 were vaccinated, of which more than 8,135 people had already received their second vaccination. This means that for every 100,000 inhabitants, 1,482 people are vaccinated, 1.48% of the total population. It’s worth putting this in perspective globally based on the week’s average data (Israel isn’t even in the charts, although based on Sunday’s data, the vaccination rate is already 28.8% there). The Hungarian result of 1482 people fits in the middle field in the figure below, the Swedes, Germans and Austrians were there in the middle of the week.

The vaccination rate in the last 7 days per 100,000 people per day is particularly fast in the British and Americans, between 430 and 270 people, but in most countries it ranges between 50 and 150 people. It can be 40 people.

The speed of spread of the epidemic is also obviously key due to the tightening of closures and the burden on health, with the situation of the Portuguese, Czechs and British now concerned about this indicator. In our case, the data for the last two weeks of about 240 people per 100,000 inhabitants is relatively low in the international arena.

The figure below shows where the epidemiological burden is now, based on the new case numbers and, as can be seen: the epidemic is spreading at an almost maximum rate in Portugal, Spain and America.

It is a very important epidemiological indicator of the number of coronavirus patients in need of intensive care per 100,000 people, and how far from the peak in a given country. The next two figures show that Czech, Spanish, Portuguese and American healthcare are now under heavy pressure.

In addition to those who need intensive care, it is obviously also necessary to look at how intense the increase in deaths per 100,000 people has been in the last two weeks. In this sense, the British, Czechs and Portuguese are unfortunately also in a bad position with a value of around 20-22 people, in which the British mutation probably already has a role. Unfortunately, the Hungarian data from around 15 people does not paint a good picture in this comparison.

Finally, the Nordea material shows a very interesting picture of the state of deaths compared to the previous peak from the epidemic in that country, and here, unfortunately, five countries are currently “running” at the current peak.

Cover Image Source: Getty Images



[ad_2]